VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 26,533 shares of the company's stock, valued at approximately $1,628,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. William Blair Investment Management LLC raised its stake in Doximity by 13.8% in the second quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company's stock valued at $320,158,000 after buying an additional 634,927 shares in the last quarter. Stratos Wealth Partners LTD. acquired a new stake in shares of Doximity during the second quarter worth about $204,000. Nordea Investment Management AB increased its position in shares of Doximity by 28.5% during the second quarter. Nordea Investment Management AB now owns 85,439 shares of the company's stock worth $5,233,000 after purchasing an additional 18,970 shares in the last quarter. New York State Teachers Retirement System increased its position in shares of Doximity by 0.6% during the second quarter. New York State Teachers Retirement System now owns 113,773 shares of the company's stock worth $6,979,000 after purchasing an additional 628 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC increased its position in shares of Doximity by 18.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 18,733 shares of the company's stock worth $1,150,000 after purchasing an additional 2,917 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Doximity
In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the sale, the director owned 16,618 shares of the company's stock, valued at approximately $948,721.62. The trade was a 10.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction that occurred on Friday, October 10th. The shares were sold at an average price of $70.84, for a total value of $354,200.00. Following the completion of the sale, the director directly owned 19,839 shares in the company, valued at $1,405,394.76. This represents a 20.13% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 37,000 shares of company stock valued at $2,635,880. 31.30% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on DOCS. JPMorgan Chase & Co. reiterated an "underweight" rating and set a $62.00 target price on shares of Doximity in a research report on Friday, October 10th. Wells Fargo & Company lifted their target price on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research report on Monday, August 4th. Raymond James Financial set a $75.00 target price on Doximity in a research report on Wednesday, September 10th. Canaccord Genuity Group lifted their target price on Doximity from $59.00 to $67.00 and gave the stock a "hold" rating in a research report on Thursday, September 18th. Finally, Needham & Company LLC lifted their target price on Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $69.37.
Check Out Our Latest Research Report on DOCS
Doximity Stock Down 2.3%
NASDAQ DOCS opened at $66.33 on Thursday. Doximity, Inc. has a 52-week low of $40.87 and a 52-week high of $85.21. The business's 50-day moving average price is $69.51 and its 200 day moving average price is $61.52. The firm has a market cap of $12.42 billion, a P/E ratio of 66.33, a P/E/G ratio of 4.10 and a beta of 1.38.
Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the company earned $0.28 EPS. The business's quarterly revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.